BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9281264)

  • 1. [The effect of enkorat on the course of epilepsy in children].
    Badalian LO; Temin PA; Iskander MB; Dunaevskaia GN; Mukhin KIu; Medvedev MI; Veselov NK; Filin VA; Aĭvazian SO
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(4):104-5. PubMed ID: 9281264
    [No Abstract]   [Full Text] [Related]  

  • 2. [The enkorat treatment of infantile spasms and the Lennox-Gastaut syndrome].
    Badalian LO; Temin PA; Medvedev MI; Mukhin KIu; Iskander MB; Kharlamov DA; Veselov NK
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(6):28-33. PubMed ID: 7740870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depamide: a preliminary report on its therapeutic efficacy in epilepsy.
    Musolino R; Gallitto G; Morgante L; Pisani F; Nisticò G; Di Perri R
    Monogr Neural Sci; 1980; 5():124-30. PubMed ID: 6798423
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and electroencephalographic study of the effects of valpramide in treating epilepsy].
    Zhou SS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Jun; 18(3):142-4. PubMed ID: 3932024
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analogs of generic preparations for the treatment of epilepsy: is their use safe?].
    Crawford P; Hall W; Chappell V; Collings J; Stewart A
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(10):29-31. PubMed ID: 11712265
    [No Abstract]   [Full Text] [Related]  

  • 6. The antiepileptic properties of N-dipropylacetamide (depamide): a clinical trial.
    Musolino R; Gallitto G; Morgante L; Pisani F; Di Perri R
    Acta Neurol (Napoli); 1980 Apr; 2(2):107-14. PubMed ID: 6771966
    [No Abstract]   [Full Text] [Related]  

  • 7. [Observation on therapeutic effect of acupoint catgut-embedding combined western medicine for epilepsy of generalized seizures type].
    Mao ZN; Gao ZG; Zhang GW; Wang SB
    Zhongguo Zhen Jiu; 2011 Jun; 31(6):509-12. PubMed ID: 21739692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of depakin in treatment-resistant epilepsy].
    Karlov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(1):33-6. PubMed ID: 8042359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication].
    Deisenhammer E
    Wien Med Wochenschr; 1977 Jun; 127(12):370-3. PubMed ID: 333779
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes of body mass index and plasma galanin in children with epilepsy following valproate sodium treatment].
    Wang KL; Shi RF; Tang HX
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):488-9. PubMed ID: 20540863
    [No Abstract]   [Full Text] [Related]  

  • 11. A brief review of valproate. A new anticonvulsant.
    Austin WH; Thorne HE
    J Maine Med Assoc; 1978 Aug; 69(8):226-7. PubMed ID: 357669
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the therapeutic scope of valproic acid].
    Schulz HU; Fröscher W; Gugler R; Eichelbaum M
    Med Welt; 1979 Jan; 30(2):59-61. PubMed ID: 364248
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of chronic N-dipropylacetamide ("depamide") treatment on plasmatic immunoglobulins of epileptic patients.
    Musolino R; Natoli M; Gallitto G; Morgante L; Serra S; Pisani F; Di Perri R
    Acta Neurol (Napoli); 1980 Apr; 2(2):115-20. PubMed ID: 6771967
    [No Abstract]   [Full Text] [Related]  

  • 14. [Etiologic factors in epilepsy as a predictor of response to anticonvulsive drug therapy].
    Feucht M; Spiel G
    Nervenarzt; 1988 Mar; 59(3):147-53. PubMed ID: 3131690
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of treatment and additional disease on pharmacokinetic of valproic acid in children with epilepsy.
    Juárez-Olguín H; Lugo-Goytia G; Flores-Murrieta F; Ruiz-García M; Lares Asseff I; Flores Pérez J
    Rev Invest Clin; 2010; 62(6):516-23. PubMed ID: 21416779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate for girls with epilepsy.
    Balen AH; Genton P
    Ann Neurol; 2000 Apr; 47(4):550-2. PubMed ID: 10762174
    [No Abstract]   [Full Text] [Related]  

  • 17. [Depakene (sodium valproate) in the treatment of epilepsy in children and adolescents: efficiency and safety].
    Petrukhin AS; Mukhin KIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(6):20-7. PubMed ID: 11517881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medical treatment of epilepsy: initiation of drug therapy.
    Livingston S; Pruce I; Pauli LL
    Pediatr Ann; 1979 Apr; 8(4):213-31. PubMed ID: 223107
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness and tolerance of valproic acid monotherapy in patients with epilepsy].
    Fröscher W; Frohn C
    Nervenarzt; 1988 May; 59(5):286-95. PubMed ID: 3136402
    [No Abstract]   [Full Text] [Related]  

  • 20. Hallucinations after withdrawal of valproic acid.
    de Laat SA; Hillegers MH; Jansen FE; Braun KP; de Graeff-Meeder ER
    Pediatrics; 2012 Jul; 130(1):e236-8. PubMed ID: 22689876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.